Differences in the Cellular Immune Response during and after Treatment of Sudanese Patients with Post-kala-azar Dermal Leishmaniasis, and Possible Implications for Outcome
Journal of Epidemiology and Global Health · 2024
DOI: 10.1007/s44197-024-00270-0 ↗Kurz gefasst
Klinische Studie (Phase II) in der Zeitschrift Journal of Epidemiology and Global Health, 2024. Verfasst von Ana Torres und 10 weiteren Autor:innen. Beteiligte Einrichtung: WHO Collaborating Centre for Leishmaniasis, Spanish National Center for Microbiology, Instituto de Salud Carlos III (ISCIII), Majadahonda (Madrid), S…. Hauptthemen laut MEDLINE: Immunity, Cellular, Leishmaniasis, Cutaneous, Leishmaniasis, Visceral. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III, Centro de Investigación Biotecnológica en Red de Enfermedades Infecciosas, Drugs for Neglected Diseases initiative.
Abstract (Originalsprache)
Background
The host cellular immune response associated with two treatments for post-kala-azar dermal leishmaniasis (PKDL) - paromomycin plus miltefosine (Arm 1), and liposomal amphotericin B plus miltefosine (Arm 2) - was examined in Sudanese patients before treatment (D0), at the end of treatment (D42), and during the post-treatment period (D180).
Methods
Whole blood samples were stimulated with soluble Leishmania antigen for 24 h (whole blood assay [WBA]) and the concentrations of Th1/Th2/Th17-associated cytokines, IP-10, PDL-1 and granzyme B were determined.
Results
The Arm 1 treatment (98.2% cure rate) induced a Th1/Th2/Th17 response, while the Arm 2 treatment (80% cure rate) induced a Th1/Th2 response. Five Arm 2 patients relapsed and showed lower IFN-γ, TNF and IL-1β concentrations at D0 than non-relapsers in this Arm. In patients with low-IFN-γ-production at D0, Arm 1 treatment led to a better host immune response and clinical outcome than Arm 2 treatment.
Conclusions
A Th1/Th2/Th17 response was associated with a higher cure rate. Patients with low IFN-γ, TNF and IL-1β before treatment are more likely to relapse if they undergo Arm 2-type treatment. Determining IFN-γ, TNF and IL-10 levels prior to treatment could help predict patients at higher risk of relapse/recovery from PKDL. Trial Registration ClinicalTrials.gov NCT03399955, Registered 17 January 2018, https://clinicaltrials.gov/study/ NCT03399955. Graphical Abstract
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- WHO Collaborating Centre for Leishmaniasis, Spanish National Center for Microbiology, Instituto de Salud Carlos III (ISCIII), Majadahonda (Madrid), Spain.
- CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain.
- Department of Clinical Pathology & Immunology, Institute for Endemic Diseases, University of Khartoum, Khartoum, Sudan.
- Drugs for Neglected Diseases Initiative, Nairobi, Kenya.
- Drugs for Neglected Diseases Initiative, Geneva, Switzerland.
- Department of Clinical Pathology & Immunology, Institute for Endemic Diseases, University of Khartoum, Khartoum, Sudan. amusa@iend.org.
Förderung
- Instituto de Salud Carlos III
- Centro de Investigación Biotecnológica en Red de Enfermedades Infecciosas
- Drugs for Neglected Diseases initiative
Zitieren
APA
Torres, A., Younis, B. M., Alamin, M., Tesema, S., Bernardo, L., Solana, J. C., Moreno, J., Mustafa, A. A., Alves, F., Musa, A. M., & Carrillo, E. (2024). Differences in the Cellular Immune Response during and after Treatment of Sudanese Patients with Post-kala-azar Dermal Leishmaniasis, and Possible Implications for Outcome. Journal of Epidemiology and Global Health. https://doi.org/10.1007/s44197-024-00270-0
Vancouver
Torres A, Younis BM, Alamin M, Tesema S, Bernardo L, Solana JC, et al. Differences in the Cellular Immune Response during and after Treatment of Sudanese Patients with Post-kala-azar Dermal Leishmaniasis, and Possible Implications for Outcome. Journal of Epidemiology and Global Health. 2024. doi:10.1007/s44197-024-00270-0
BibTeX
@article{Torres2024,
author = {Torres, Ana and Younis, Brima Musa and Alamin, Mohammed and Tesema, Samuel and Bernardo, Lorena and Solana, Jose Carlos and Moreno, Javier and Mustafa, Alaa-Aldeen and Alves, Fabiana and Musa, Ahmed Mudawi and Carrillo, Eugenia},
title = {Differences in the Cellular Immune Response during and after Treatment of Sudanese Patients with Post-kala-azar Dermal Leishmaniasis, and Possible Implications for Outcome},
journal = {Journal of Epidemiology and Global Health},
year = {2024},
doi = {10.1007/s44197-024-00270-0}
}
EUVIMED